SELLAS LIFE SCIENCES GROUP, INC.

Analyst Reco. SELLAS Life Sciences Group, Inc.

Equities

SLS

US81642T2096

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-08 EDT			5-day change	1st Jan Change
1.28 ^USD	-3.03%		+3.23%	+20.75%

05-01	SELLAS Life Sciences Group, Inc. Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level	CI
04-29	SELLAS Life Sciences Group, Inc. Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cantor Fitzgerald Adjusts Price Target on SELLAS Life Sciences Group to $6 From $10, Keeps Overweight Rating	22-06-28	MT
Alliance Global Adjusts Price Target on SELLAS Life Sciences Group to $14 From $16.50, Reiterates Buy Rating	22-04-08	MT
Ladenburg Thalmann Starts SELLAS Life Sciences Group at Buy with $15 Price Target	22-02-07	MT
Maxim Group Adjusts SELLAS Life Sciences Group Price Target to $12 From $21, Maintains Buy Rating	22-02-02	MT
Cantor Fitzgerald Adjusts Price Target on SELLAS Life Sciences to $16 From $18, Reiterates Overweight Rating	21-12-03	MT
SELLAS LIFE SCIENCES : Cantor Fitzgerald Starts SELLAS Life Sciences Group at Overweight With $18 Price Target	21-07-21	MT
SELLAS LIFE SCIENCES : Maxim Adjusts Price Target on SELLAS Life Sciences Group to $21 From $12, Keeps Buy Rating	21-06-25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW